Business Description
Dyadic International is a US-based biotechnology company that develops and sells industrial enzymes and biological products for use in pharmaceuticals, food and nutrition, and industrial markets worldwide. Its core technology is the C1 platform, a protein production system that enables fast, large-scale manufacturing of biologics at competitive costs. The company is advancing a COVID-19 vaccine candidate through clinical trials and maintains active partnerships with research institutions and biotech firms across Europe, Africa, and beyond. Founded in 1979, Dyadic is headquartered in Jupiter, Florida.
